TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Bristol Myers Squibb’s Zeposia shows promising results in phase 3 True North trial for ulcerative colitis treatment Bristol Myers Squibb (BMS) has reported significant success in its phase 3 True North clinical trial, evaluating the… bypharmanewsdailyOctober 11, 2020